Analysis of information sources in references of the Wikipedia article "ההיסטוריה של פיתוח החיסון נגד נגיף הקורונה" in Hebrew language version.
{{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה)תחזוקה - ציטוט: multiple names: authors list (link){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite journal}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה)Pfizer is one of various vaccine manufacturers participating in Operation Warp Speed as a supplier of a potential COVID-19 vaccine," Castillo said in an email. "While Pfizer did reach an advanced purchase agreement with the U.S. government, the company did not accept (Biomedical Advanced Research and Development Authority) funding for the research and development process. All the investment for R&D was made by Pfizer at risk. Dr. Jansen was emphasizing that last point.
{{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link)CEPI estimates that developing up to three vaccines in the next 12–18 months will require an investment of at least תבנית:US$ billion. This estimate includes Phase 1 clinical trials of eight vaccine candidates, progression of up to six candidates through Phase 2 and 3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה) Text was copied from this source which is European Medicines Agency. Reproduction is authorized provided the source is acknowledged.{{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה) Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.{{cite press release}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה) {{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite press release}}
: (עזרה){{cite news}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link)CEPI estimates that developing up to three vaccines in the next 12–18 months will require an investment of at least תבנית:US$ billion. This estimate includes Phase 1 clinical trials of eight vaccine candidates, progression of up to six candidates through Phase 2 and 3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)CEPI estimates that developing up to three vaccines in the next 12–18 months will require an investment of at least תבנית:US$ billion. This estimate includes Phase 1 clinical trials of eight vaccine candidates, progression of up to six candidates through Phase 2 and 3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines.
{{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה)It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. [The] WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale.
{{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה)תחזוקה - ציטוט: multiple names: authors list (link){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite news}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה)It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. [The] WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale.
{{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite web}}
: (עזרה){{cite press release}}
: (עזרה){{cite web}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite news}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite news}}
: (עזרה){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה)תחזוקה - ציטוט: postscript (link){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: (עזרה){{cite journal}}
: תחזוקה - ציטוט: postscript (link)